Formation of structural and functional changes in the myocardium in individuals with different metabolic phenotypes: A literature review

Cardiovascular mortality still takes leading places among causes of mortality from different disease in developed countries including Russian Federation. Influence of adipose tissue excess on myocardium is widely discussed in scientific literature. The concept of metabolic phenotypes was suggested as a new way for study of impact of obesity and concomitant metabolic disorders in to the risk of cardiovascular diseases and mortality from them. In this review we discussed the accumulated experience of the Russian and international trials about structural and functional characteristics of myocardium described with various instrumental methods of diagnosis. Special attention is focused on the description of echocardiography as the most available visualizing method, actual diagnostic criteria of disturbances are provided according to Russian and international guidelines. Features and methods of diagnosis of diastolic dysfunction and cardiac remodeling in terms of heart failure with preserved ejection fraction in people with various metabolic phenotypes are discussed. The majority of authors declare the absence of evident decrease of systolic function, as a result the estimation of diastolic dysfunction is very actual. Issues connected to historical transformation of the term obesity paradox and obese cardiopathy, myocardial fat ectopy are covered. The results of experimental and morphological studies present the facts about different impact of adipose tissue and metabolic disorders to development changes in myocardium.

1. Bots SH, Peters SAE, Woodward M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health. 2017;2(2):e000298. https://doi.org/10.1136/bmjgh-2017-000298.

2. Iacobellis G, Sharma AM. Obesity and the heart: redefinition of the relationship. Obes Rev. 2007;8(1):35–39. https://doi.org/10.1111/j.1467-789X.2006.00257.x.

3. Piché ME, Tchernof A, Després JP. Obesity Phenotypes, Diabetes, and Cardio - vascular Diseases. Circ Res. 2020;126(11):1477–1500. https://doi.org/10.1161/CIRCRESAHA.120.316101.

4. Шляхто ЕВ, Звартау НЭ, Виллевальде СВ, Яковлев АН, Соловьева АЕ, Федоренко АА и др. Значимость оценки распространенности и мониторинга исходов у пациентов с сердечной недостаточностью в России. Российский кардиологический журнал. 2020;25(12):4204. https://doi.org/10.15829/1560-4071-2020-4204.

5. Norhammar A, Bodegard J, Vanderheyden M, Tangri N, Karasik A, Maggioni AP et al. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart. 2023;109(7):548–556. https://doi.org/10.1136/heartjnl-2022-321702.

6. Van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9. https://doi.org/10.1186/1472-6823-14-9.

7. Терещенко СН, Галявич АС, Ускач ТМ, Агеев ФТ, Арутюнов ГП, Беграмбекова ЮЛ и др. Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083. https://doi.org/10.15829/1560-4071-2020-4083.

8. Кузнецова НО, Сагирова ЖН, Губина АЮ, Захаров ИП, Валиев ГО, Мельничук АА и др. Оценка функции миокарда у пациентов с хронической сердечной недостаточностью при помощи регистратора одноканальной электрокардиограммы Вестник новых медицинских технологий. 2022;29(1):46–52. https://doi.org/10.24412/1609-2163-2022-1-46-52.

9. He J, Yang W, Wu W, Sun X, Li S, Yin G et al. Clinical features, myocardial strain and tissue characteristics of heart failure with preserved ejection fraction in patients with obesity: A prospective cohort study. EClinicalMedicine. 2022;55:101723. https://doi.org/10.1016/j.eclinm.2022.101723.

10. Исламова МР, Лазарев ПВ, Сафарова АФ, Кобалава ЖД. Эхокардиографические возможности оценки функции правого желудочка и правожелудочково-артериального сопряжения при хронической сердечной недостаточности Кардиология: новости, мнения, обучение. 2018;6(3):51–58. https://doi.org/10.24411/2309-1908-2018-13004.

11. Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297–3317. https://doi.org/10.1093/eurheartj/ehz641.

12. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–e1032. https://doi.org/10.1161/CIR.0000000000001063.

13. Гриценко ОВ, Чумакова ГА, Трубина ЕВ. Возможности speckle trackingэхокардиографии для диагностики дисфункции миокарда. CardioСоматика. 2021;12(1):5–10. https://doi.org/10.26442/22217185.2021.1.200756.

14. Mandviwala TM, Basra SS, Khalid U, Pickett JK, Przybylowicz R, Shah T et al. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020;44(7):1561–1567. https://doi.org/10.1038/s41366-020-0563-1.

15. Крюков НА, Рыжков АВ, Сухова ИВ, Ананьевская ПВ, Фокин ВА, Гордеев МЛ. Сравнительная оценка диагностической ценности эхокардиографии с магнитно-резонансной томографией в определении жизнеспособности дисфункционального миокарда. Российский кардиологический журнал. 2021;26(8):4407. https://doi.org/10.15829/1560-4071-2021-4407.

16. Сергиенко ВБ, Аншелес АА. Позитронная эмиссионная томография в кардиологической практике. Терапевтический архив. 2023;95(7):531–536. https://doi.org/10.26442/00403660.2023.07.202278.

17. Хачирова ЭА, Самойленко ЛЕ, Шевченко ОП. Оценка диастолической функции миокарда у пациентов с болевым синдромом в грудной клетке и ангиографически неизменными коронарными артериями методом синхронизированной с ЭКГ однофотонной эмиссионной компьютерной томографии. Вестник РГМУ. 2019;(1):15–21. Режим доступа: https://vestnik.rsmu.press/archive/2019/1/2/content?lang=ru.

18. Завадовский КВ, Веснина ЖВ, Анашбаев ЖЖ, Мочула АВ, Сазонова СИ, Ильюшенкова ЮН и др. Современное состояние ядерной кардиологии в Российской Федерации. Российский кардиологический журнал. 2022;27(12):5134. https://doi.org/10.15829/1560-4071-2022-5134.

19. Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132(17):1639–1647. https://doi.org/10.1161/CIRCULATIONAHA.114.015000.

20. Reis JP, Allen N, Gunderson EP, Lee JM, Lewis CE, Loria CM et al. Excess body mass index- and waist circumference-years and incident cardiovascular disease: the CARDIA study. Obesity (Silver Spring). 2015;23(4):879–885. https://doi.org/10.1002/oby.21023.

21. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95(12):5419–5426. https://doi.org/10.1210/jc.2010-1378.

22. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11(6):363–371. https://doi.org/10.1038/nrendo.2015.58.

23. Shah RV, Anderson A, Ding J, Budoff M, Rider O, Petersen SE et al. Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging. 2017;10(9):1016–1027. https://doi.org/10.1016/j.jcmg.2016.10.024.

24. Kenchaiah S, Ding J, Carr JJ, Allison MA, Budoff MJ, Tracy RP et al. Pericardial Fat and the Risk of Heart Failure. J Am Coll Cardiol. 2021;77(21):2638–2652. https://doi.org/10.1016/j.jacc.2021.04.003.

25. Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction. Circulation. 2017;136(1):6–19. https://doi.org/10.1161/CIRCULATIONAHA.116.026807.

26. Sciacqua A, Cimellaro A, Mancuso L, Miceli S, Cassano V, Perticone M et al. Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects. Nutrients. 2020;12(2):412. https://doi.org/10.3390/nu12020412.

27. Dong B, Yao Y, Xue R, Liang W, He J, Wei F et al. Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial. BMC Med. 2022;20(1):423. https://doi.org/10.1186/s12916-022-02626-4.

28. Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714–724. https://doi.org/10.1016/S2213-8587(18)30137-2.

29. Постоева АВ, Дворяшина ИВ, Сельченкова ЕИ. Использование концепции метаболических фенотипов для оценки сердечно-сосудистого риска: обзор литературы. Эндокринология: новости, мнения, обучение. 2024;13(1):80–88. https://doi.org/10.33029/2304-9529-2024-13-1-80-88.

30. Imbalzano E, Russo GT, Giandalia A, Sciacqua A, Orlando L, Russo V et al. Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients. Biomedicines. 2022;10(2):424. https://doi.org/10.3390/biomedicines10020424.

31. Lee HJ, Kim HL, Lim WH, Seo JB, Kim SH, Zo JH, Kim MA. Subclinical alterations in left ventricular structure and function according to obesity and metabolic health status. PLoS ONE. 2019;14(9):e0222118. https://doi.org/10.1371/journal.pone.0222118.

32. Wang Y, Liang J, Zheng S, He A, Chen C, Zhao X et al. Combined associations of obesity and metabolic health with subclinical left ventricular dysfunctions: Danyang study. ESC Heart Fail. 2021;8(4):3058–3069. https://doi.org/10.1002/ehf2.13403.

33. Wang P, Liu M, Zhuang X, Guo Y, Xiong Z, He L et al. Association of metabolically healthy obesity in young adulthood with myocardial structure and function. Int J Obes (Lond). 2023;47(5):399–405. https://doi.org/10.1038/s41366-023-01288-3.

34. Ahmad MI, Mongraw-Chaffin M, Lewis KH, Chen H, Ard JD, Soliman EZ. Association of Obesity Phenotypes with Electrocardiographic Markers of Poor Outcomes in the General Population. Obesity (Silver Spring). 2019;27(12):2076–2083. https://doi.org/10.1002/oby.22647.

35. Zhao H, Huang R, Jiang M, Wang W, Chai Y, Liu Q et al. Myocardial Tissue-Level Characteristics of Adults With Metabolically Healthy Obesity. JACC Cardiovasc Imaging. 2023;16(7):889–901. https://doi.org/10.1016/j.jcmg.2023.01.022.

36. Olatunbosun PP, El Hunjul GN, Patel A, Abbas RH, Mody S, Masalha A et al. Heart failure in patients with metabolic syndrome X. Discoveries (Craiova). 2023;11(1):e162. https://doi.org/10.15190/d.2023.1.

37. Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745–1807. https://doi.org/10.1152/physrev.00030.2020.

38. Rayner JJ, Peterzan MA, Watson WD, Clarke WT, Neubauer S, Rodgers CT et al. Myocardial Energetics in Obesity: Enhanced ATP Delivery Through Creatine Kinase With Blunted Stress Response. Circulation. 2020;141(14):1152–1163. https://doi.org/10.1161/CIRCULATIONAHA.119.042770.

39. Brandt MM, Nguyen ITN, Krebber MM, van de Wouw J, Mokry M, Cramer MJ et al. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction. J Cell Mol Med. 2019;23(10):6666–6678. https://doi.org/10.1111/jcmm.14542.

40. Torres-Jacome J, Ortiz-Fuentes BS, Bernabe-Sanchez D, Lopez-Silva B, Velasco M, Ita-Amador ML, Albarado-Ibañez A. Ventricular Dysfunction in Obese and Nonobese Rats with Metabolic Syndrome. J Diabetes Res. 2022:9321445. https://doi.org/10.1155/2022/9321445.